No profile data available.
Oxygenta Pharmaceutical Limited (OXYGENTAPH.BO) is a healthcare company in the drug manufacturing contractors industry, based in Hyderabad, India, with about 170 full-time employees.
It reported revenue of 1.09 billion INR for fiscal year 2025, up 175.7% from fiscal year 2024, and net income of -96.83 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 339.31 million INR, up 2.2% from a year before. Its market capitalization was 1.80 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers active pharmaceuticals ingredients, commercial intermediates, and organic fine chemicals, as well as formulations. S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022.
Oxygenta Pharmaceutical reported 1.09 billion INR in revenue for fiscal year 2025, up 175.7% from 396.42 million INR in fiscal year 2024. In Q3 2026 revenue was 339.31 million INR.
1.80 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Coral Laboratories Limited (CORALAB.BO), Syschem (India) Limited (SYSCHEM.BO), Nectar Lifesciences Limited (NECLIFE.NS), Smruthi Organics Limited (SMRUTHIORG.BO).